Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Associates In Research, Inc.
mi
from
Fresno, CA
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Associates In Research, Inc.
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Dermatology Associates
mi
from
Los Angeles, CA
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Dermatology Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Stanford University School of Medicine
mi
from
Redwood City, CA
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Stanford University School of Medicine
mi
from
Redwood City, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Atlantic Skin & Cosmetic Surgery Group
mi
from
Wilmington, DE
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Atlantic Skin & Cosmetic Surgery Group
mi
from
Wilmington, DE
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Renstar Medical Research
mi
from
Ocala, FL
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
NorthShore University HealthSystem
mi
from
Skokie, IL
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
NorthShore University HealthSystem
mi
from
Skokie, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Dawes Fretzin Dermatology Group
mi
from
Indianapolis, IN
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Dawes Fretzin Dermatology Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Dermatology & Advanced Aesthetics
mi
from
Lake Charles, LA
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Dermatology & Advanced Aesthetics
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Minnesota Clinical Study Center
mi
from
Fridley, MN
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Central Dermatology
mi
from
St. Louis, MO
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Central Dermatology
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
UMDNJ/Robert Wood Johnson
mi
from
New Brunswick, NJ
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
UMDNJ/Robert Wood Johnson
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Wright State University
mi
from
Dayton, OH
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Wright State University
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Allergy Asthma Dermatology Research Center
mi
from
Lake Oswego, OR
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Allergy Asthma Dermatology Research Center
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Northwest Cutaneous Research Specialists
mi
from
Portland, OR
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Northwest Cutaneous Research Specialists
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Oregon Medical Research Center, PC
mi
from
Portland, OR
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Oregon Medical Research Center, PC
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Rivergate Dermatology Clinical Research
mi
from
Goodlettsville, TN
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Rivergate Dermatology Clinical Research
mi
from
Goodlettsville, TN
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Modern Research Associates
mi
from
Dallas, TX
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Modern Research Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Dermatology Associates of Seattle
mi
from
Seattle, WA
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Dermatology Associates of Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Aurora Advanced Healthcare
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated:  9/11/2015
Stratica Medical
mi
from
Edmonton,
Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
Status: Enrolling
Updated: 9/11/2015
Stratica Medical
mi
from
Edmonton,
Click here to add this to my saved trials
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Status: Enrolling
Updated:  9/15/2015
International Dermatology Research, Inc.
mi
from
Miami, FL
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Status: Enrolling
Updated: 9/15/2015
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Status: Enrolling
Updated:  9/15/2015
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Status: Enrolling
Updated: 9/15/2015
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Status: Enrolling
Updated:  9/15/2015
DermResearch, Inc.
mi
from
Austin, TX
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10
A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 Aqueous Hydrogel to Plaque Psoriasis
Status: Enrolling
Updated: 9/15/2015
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) as a Severity and Response Biomarker in Psoriatic Arthritis
Status: Enrolling
Updated:  9/17/2015
University of Rochester
mi
from
Rochester, NY
National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) as a Severity and Response Biomarker in Psoriatic Arthritis
Status: Enrolling
Updated: 9/17/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of Vitamin D Levels in Psoriasis Patients
Evaluation of Vitamin D Levels in Psoriasis Patients
Status: Enrolling
Updated:  10/7/2015
University of California Irvine, Dermatology
mi
from
Irvine, CA
Evaluation of Vitamin D Levels in Psoriasis Patients
Evaluation of Vitamin D Levels in Psoriasis Patients
Status: Enrolling
Updated: 10/7/2015
University of California Irvine, Dermatology
mi
from
Irvine, CA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Coastal Carolina Research
mi
from
Mobile, AL
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Coastal Carolina Research
mi
from
Mobile, AL
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Sierra Medical Research
mi
from
Fresno, CA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Sierra Medical Research
mi
from
Fresno, CA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Therapeutics Clinical Research
mi
from
San Diego, CA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Ameriderm Research
mi
from
Ormond Beach, FL
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Ameriderm Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Atlanta Dermatology, Vein & Research Ctr
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Dawes Fretzin Clinical Research Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Medical Development Centers, LLC
mi
from
Opelousas, LA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Medical Development Centers, LLC
mi
from
Opelousas, LA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Central Dermatology
mi
from
St. Louis, MO
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Central Dermatology
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Dartmouth-Hitchcock Medical Center, Section of Dermatology
mi
from
Lebanon, NH
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Dartmouth-Hitchcock Medical Center, Section of Dermatology
mi
from
Lebanon, NH
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Skin Search of Rochester, Inc
mi
from
Rochester, NY
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Skin Search of Rochester, Inc
mi
from
Rochester, NY
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Dermatology Consulting Services
mi
from
High Point, NC
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Wilmington Dermatology Center
mi
from
Wilmington, NC
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Wilmington Dermatology Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Radiant Research, Inc
mi
from
Columbus, OH
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Radiant Research, Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Palmetto Clinical Trial Services
mi
from
Greenville, SC
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Palmetto Clinical Trial Services
mi
from
Greenville, SC
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Arlington Research Center
mi
from
Arlington, TX
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Arlington Research Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
DBA Dermatology Associates
mi
from
Seattle, WA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
DBA Dermatology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
University of Alabama (UAB) Dermatology
mi
from
Birmingham, AL
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
University of Alabama (UAB) Dermatology
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Clinical Science Institute
mi
from
Santa Monica, CA
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Clinical Science Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Visions Clinical Research
mi
from
Boynton Beach, FL
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Visions Clinical Research
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
Ameriderm Research
mi
from
Jacsonville, FL
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
Ameriderm Research
mi
from
Jacsonville, FL
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
NorthShore University HealthSystem
mi
from
Skokie, IL
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
NorthShore University HealthSystem
mi
from
Skokie, IL
Click here to add this to my saved trials
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated:  10/12/2015
The Southbend Clinic, LLC
mi
from
South Bend, IN
Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients
Status: Enrolling
Updated: 10/12/2015
The Southbend Clinic, LLC
mi
from
South Bend, IN
Click here to add this to my saved trials